Contemporary management of borderline resectable pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive tumors, with a low rate of survival, likely due to the tendency of the tumor for early local and distant spread. Pancreatic cancer accounts for about 3% of all cancers in the US and about 7% of all cancer deaths. Surgical res...

Descripción completa

Detalles Bibliográficos
Autores principales: Lekka, Kyriaki, Tzitzi, Evanthia, Giakoustidis, Alexander, Papadopoulos, Vassilios, Giakoustidis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Hepato-Biliary-Pancreatic Surgery 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558121/
https://www.ncbi.nlm.nih.gov/pubmed/31225409
http://dx.doi.org/10.14701/ahbps.2019.23.2.97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558121/
https://www.ncbi.nlm.nih.gov/pubmed/31225409
http://dx.doi.org/10.14701/ahbps.2019.23.2.97

Ejemplares similares